Delivery Order SPE2DB22D2007-SPE2DB25FJ0SU

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 100 capsules of the medication Tacrolimus 0.5 mg (immediate release) to the Defense Logistics Agency (DLA). The contract, a firm fixed-price delivery order valued at $1,856.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of October 21,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,622.72, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used in transplant patients. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $1,310.40 for the supply of Tacrolimus 1 mg capsules. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating an open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of 5 mg Tacrolimus capsules. The $1,903.26 contract has a period of performance through March 22, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is the sole awardee of a $999,999,999.00 indefinite delivery contract from DLA to deliver pharmaceuticals...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ15H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The contract has a ceiling value of $2,408.32 and was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,462.10 firm-fixed-price delivery order is for the supply of 100 units of the medication Tacrolimus 1 mg capsules. This contract does not have a set-aside designation, indicating open competition. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,929.40 firm fixed-price delivery order is for the supply of 100 units of the medication Tacrolimus 1 mg capsule (immediate release) to support military and federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,925.04, is for the delivery of TACROLIMUS 0.5 MG CAPSULE (IR) 100S, a generic pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 15, 2024 and is structured as a Firm Fixed Price Delivery Order. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 5 mg capsules (immediate-release). The contract is valued at $4,320.54 and has a period of performance through September 26, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is used to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tacrolimus 5 mg capsules (immediate release) in 100-count units. The $3,871.10 contract is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0SU
    Delivery Order

This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0SU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,848.79 delivery order contract is for the supply of Tacrolimus 1 mg capsules, a medication used to prevent organ rejection after transplant.

The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This positions the company as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/17/25, 6:14 PM